Factors Associated with Possible Cannabis Use Disorder among Adults Using Medical Cannabis in Florida: A Cross-Sectional Study [0.03%]
佛罗里达州使用医用大麻的成年人中可能发生 cannabis 使用障碍的相关因素：一项横断面研究
Robert L Cook,Sophie Maloney,Hanzhi Gao et al.
Robert L Cook et al.
Introduction: The number of people using medical cannabis has increased in the United States, but little is known about the prevalence or risk factors for Cannabis Use Disorder (CUD) in this population. We sought to estim...
Oral Cannabidiol in the Treatment of Myofascial Pain Disorder of the Temporomandibular Region: A Placebo-Controlled Randomized Clinical Trial [0.03%]
舌下给药大麻二酚治疗颞下颌肌筋膜痛的安慰剂对照随机临床试验
Gwendolyn S Reeve,Rachel B Kutler,Adam Abel et al.
Gwendolyn S Reeve et al.
Introduction: The efficacy of oral cannabidiol (CBD) for the management of myofascial pain disorder (MPD) of the temporomandibular region remains understudied. Therefore, the purpose of this study was to determine whether...
Quantitative Analysis of Cannabinoid Therapy in Prostate Cancer: Integrating Biomarkers, Imaging, and Patient Outcomes [0.03%]
大麻素治疗前列腺癌的定量分析：整合生物标志物、影像学和患者预后指标
Shiksha Gallow,Ashley Hilton Adrian Ross,Brenda Thabisile Mkhize et al.
Shiksha Gallow et al.
Introduction: Cannabinoids are increasingly used by cancer patients for symptom relief, yet clinical evidence on their effect in prostate cancer remains limited. This study evaluated the association between cannabinoid th...
A Randomized, Single-Dose, Single-Sequence, Two-Arm (Fasting and Fed), Open-Label Study on the Oral Pharmacokinetics of a Nanodispersible Cannabidiol Solution (150 mg/mL) [0.03%]
一项单次给药、单序列、两组（空腹和餐后）、开放标签研究，评估一种纳微乳大麻二酚溶液（150毫克/毫升）口服药代动力学的随机试验
Prasad Rao Gundugurti,Monila Nadikudi,Ramyasree Thatikonda et al.
Prasad Rao Gundugurti et al.
Introduction: Cannabidiol (CBD), a non-psychoactive phytocannabinoid, attributed to its therapeutic benefits and positive safety profile is being studied for its potential to treat various medical conditions. The low oral...
Amie J Goodin,Jeevan Jyot,Robert L Cook et al.
Amie J Goodin et al.
Effect of Cannabigerol on Sleep and Quality of Life in Veterans: A Decentralized, Randomized, Placebo-Controlled Trial [0.03%]
大麻萜酚对退伍军人睡眠和生活质量的影响：一项去中心化、随机、安慰剂对照试验
Chris R Emerson,Courtney E Webster,Eric J Daza et al.
Chris R Emerson et al.
Introduction: This decentralized, randomized, triple-blind, placebo-controlled study evaluated efficacy and safety of oral cannabigerol (CBG) in Veterans with sleep issues. ...
Juan G Perez,Liva G LaMontagne,Gabriela A Garcia et al.
Juan G Perez et al.
Background: At least 60% of individuals with anxiety disorders report sleep disturbances, which might be explained by shared physiological mechanisms, including cortisol dysregulation and executive function skills disrupt...
UK Medical Cannabis Registry: An Updated Analysis of Cannabis-Based Medicinal Products for Multiple Sclerosis [0.03%]
英国医学大麻登记处：多发性硬化症的基于大麻的药物治疗的最新分析研究报告
Yashvi Shah,Simon Erridge,Evonne Clarke et al.
Yashvi Shah et al.
Introduction: Multiple sclerosis (MS) is a neurodegenerative disease presenting with a wide range of motor, sensory, and psychiatric symptoms. Although nabiximols is licensed for MS-induced spasticity, cannabis-based medi...
Cannabis Certifications for Severe Chronic and Intractable Pain: Geographic Patterns across Pennsylvania, USA [0.03%]
美国宾夕法尼亚州大麻严重慢性难治性疼痛资格认证的地域模式分布图
Sanya K Mehta,Lorraine D Tusing,Ahmad Higazy et al.
Sanya K Mehta et al.
Introduction: Chronic pain is the most common qualifying condition found in states with legal (certified) access to medical cannabis (MC). We assessed the geographic distribution of MC certifications for severe chronic or...
Marieke Vringer,Michel Cronie,Aniek Remmerswaal et al.
Marieke Vringer et al.
Introduction: The endocannabinoid system plays a role in sleep-wake regulation. In clinical practice, people with central disorders of hypersomnolence (CDH) frequently report use of cannabis. ...